Pre-clinical efficacy of a C4BP hexameric IgG Fc fusion protein against Neisseria gonorrhoeae
PLOS One · 2026
DOI: 10.1371/journal.pone.0350782 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Jutamas Shaughnessy und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, Un…. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Recombinant Fusion Proteins, Complement C4b-Binding Protein, Immunoglobulin G. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Gonorrhea is the second most common bacterial sexually transmitted infection and affects about 80 million people worldwide annually. The causative agent, Neisseria gonorrhoeae , has become resistant to almost every antibiotic used for its treatment. There is no licensed vaccine against gonorrhea. Therefore, there is an urgent need to develop novel prevention and treatment strategies to curb the spread of gonorrhea. The gonococcus has evolved several mechanisms to evade complement, a key arm of immune defenses against this pathogen, including binding of the human complement inhibitors Factor H (FH) and C4b-binding protein (C4BP). We previously showed that chimeric molecules fusing the gonococcal binding domains of FH and C4BP to IgG Fc and IgM Fc, respectively, mediate complement-dependent killing of gonococci in vitro and attenuate gonococcal colonization of mouse vaginas when administered topically. Here, we fused C4BP domains 1 and 2, which contain the gonococcal binding region, to IgG Fc bearing the IgM tail-piece to facilitate Fc hexamerization. This molecule, called C4BP-Hexa IgG Fc, showed ~650-fold greater complement-dependent bactericidal activity on a molar basis than monomeric C4BP-IgG1 Fc. C4BP-Hexa IgG Fc enhanced association with and uptake by human neutrophils in a complement-independent manner. Despite ‘off-target’ complement activation in solution, C4BP-Hexa IgG Fc reduced both the duration and the bacterial burden of gonococcal vaginal colonization in human FH and C4BP transgenic mice when administered intravaginally daily. In conclusion, we show proof-of-concept of the efficacy of a hexameric C4BP IgG Fc fusion molecule against N. gonorrhoeae , which could aid in the fight against this multidrug-resistant pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
- KBio Inc., Owensboro, Kentucky, United States of America.
- Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, United States of America.
- Planet Biotechnology, Inc., Hayward, California, United States of America.
- ZabBio, San Diego, California, United States of America.
ORCID-Profile: Sandy P Fontes, Y Tran, Keith L Wycoff, Kevin J Whaley, Alison K Criss, Sanjay Ram
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Shaughnessy, J., Du, J., Broden, M. W., Gulati, S., Zheng, B., Nowak, N., Telford, G., Fontes, S. P., Tran, Y., Wycoff, K. L., Whaley, K. J., Criss, A. K., & Ram, S. (2026). Pre-clinical efficacy of a C4BP hexameric IgG Fc fusion protein against Neisseria gonorrhoeae. PLOS One. https://doi.org/10.1371/journal.pone.0350782
Vancouver
Shaughnessy J, Du J, Broden MW, Gulati S, Zheng B, Nowak N, et al. Pre-clinical efficacy of a C4BP hexameric IgG Fc fusion protein against Neisseria gonorrhoeae. PLOS One. 2026. doi:10.1371/journal.pone.0350782
BibTeX
@article{Shaughnessy2026,
author = {Shaughnessy, Jutamas and Du, Jintang and Broden, Mary Wakim and Gulati, Sunita and Zheng, Bo and Nowak, Nancy and Telford, Gretchen and Fontes, Sandy P and Tran, Y and Wycoff, Keith L and Whaley, Kevin J and Criss, Alison K and Ram, Sanjay},
title = {Pre-clinical efficacy of a C4BP hexameric IgG Fc fusion protein against Neisseria gonorrhoeae},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0350782}
}
EUVIMED